Related Experiment Video
Updated: May 5, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Thyroid dysfunction and risk of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy: a
Weijie Zhang1, Fushi Piao2, Wei Fu3
1Department of Emergency, Fuwai Central China Cardiovascular Hospital, Zhengzhou, Henan, China.
Insights
Thyroid dysfunction, including subclinical and overt hypothyroidism, increases the risk of atrial fibrillation (AF) in patients with hypertrophic obstructive cardiomyopathy (HOCM). Thyroid optimization may be key for AF risk stratification in HOCM patients.
Area of Science:
- Cardiology
- Endocrinology
- Internal Medicine
Background:
- Atrial fibrillation (AF) is a significant arrhythmia in hypertrophic obstructive cardiomyopathy (HOCM).
- The link between thyroid dysfunction and AF in HOCM patients is not well-established.
- Thyroid hormones critically influence cardiac electrophysiology and atrial remodeling.
Purpose of the Study:
- To investigate the association between thyroid-stimulating hormone (TSH) levels and incident AF in patients with HOCM.
- To determine if thyroid dysfunction impacts AF risk in this specific patient population.
- To explore the potential role of thyroid function in AF risk stratification for HOCM patients.
Main Methods:
- Retrospective analysis of 755 HOCM patients across three tertiary centers (2019-2024).
- Patients categorized by TSH levels: <0.55, 0.55-2.49 (reference), 2.50-9.99, and ≥10.00 mIU/L.
- Multivariable logistic regression and Cox proportional hazards regression analyses were employed.
Main Results:
- Elevated TSH levels (2.50-9.99 and ≥10.00 mIU/L) were independently associated with a higher risk of incident AF.
- Odds Ratios (OR) for AF increased with TSH levels (e.g., OR 4.306 for TSH ≥10.00 mIU/L).
- Restricted cubic spline analysis revealed a U-shaped association between TSH and AF risk.
Conclusions:
- Both subclinical and overt hypothyroidism are linked to increased incident AF risk in HOCM patients.
- Thyroid function status is a potential factor for AF risk stratification in HOCM.
- Further prospective studies are needed to confirm if thyroid optimization can mitigate AF risk in HOCM.
Background:
Atrial fibrillation (AF) is a common and clinically important arrhythmia in patients with hypertrophic obstructive cardiomyopathy (HOCM). Thyroid dysfunction influences atrial electrophysiology and remodeling; however, its association with AF in HOCM remains poorly defined.
Methods:
We retrospectively analyzed 755 consecutive patients with HOCM (mean age 48.65 ± 14.12 years; 60.0% male) from three tertiary centers (2019-2024). Patients were categorized by thyroid-stimulating hormone (TSH) levels as <0.55, 0.55-2.49 (reference), 2.50-9.99, and ≥10.00 mIU/L. Multivariable logistic regression and restricted cubic spline analyses were performed. Supplementary Cox proportional hazards regression was performed as a sensitivity analysis using exact event timing.
Results:
During 12-month follow-up, 107 patients developed incident AF (cumulative incidence, 14.2%). After multivariable adjustment, elevated TSH was independently associated with AF (TSH 2.50-9.99 mIU/L: OR 1.981, 95% CI 1.126-3.512; TSH ≥10.00 mIU/L: OR 4.306, 95% CI 1.061-17.485). Supplementary Cox regression yielded consistent results (TSH 2.50-9.99 mIU/L: HR 1.824, 95% CI 1.087-3.061; TSH ≥10.00 mIU/L: HR 3.685, 95% CI 1.018-13.337). Restricted cubic spline analysis demonstrated a U-shaped association between TSH and AF risk.
Conclusions:
In this multicenter retrospective cohort of patients with HOCM, both subclinical and overt hypothyroidism were associated with a higher risk of incident AF. Our findings indicate that thyroid function status may be associated with AF risk and could potentially contribute to risk stratification; prospective interventional studies are warranted to determine whether thyroid optimization can reduce AF risk.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Hyperthyroidism II: Pathophysiology
Hypothyroidism II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy

